Literature DB >> 21392254

High levels of protein C are determined by PROCR haplotype 3.

M C Pintao1, S Roshani, M C H de Visser, C Tieken, M W T Tanck, I M Wichers, J C M Meijers, F R Rosendaal, S Middeldorp, P H Reitsma.   

Abstract

BACKGROUND: Genetic determinants of plasma levels of protein C (PC) are poorly understood. Recently, we identified a locus on chromosome 20 determining high PC levels in a large Dutch pedigree with unexplained thrombophilia. Candidate genes in the LOD-1 support interval included FOXA2, THBD and PROCR.
OBJECTIVES: To examine these candidate genes and their influence on plasma levels of PC. PATIENTS/
METHODS: Exons, promoter and 3'UTR of the candidate genes were sequenced in 12 family members with normal to high PC levels. Four haplotypes of PROCR, two SNPs in the neighboring gene EDEM2 and critical SNPs encountered during resequencing were genotyped in the family and in a large group of healthy individuals (the Leiden Thrombophilia Study (LETS) controls). Soluble endothelial protein C receptor (sEPCR) and soluble thrombomodulin (sTM) plasma levels were measured in the family.
RESULTS: PROCR haplotype 3 (H3) and FOXA2 rs1055080 were associated with PC levels in the family but only PROCR H3 was also associated with plasma levels in the healthy individuals. Carriers of both variants had higher PC levels than carriers of only PROCR H3 in the family but not in healthy individuals, suggesting that a second determinant is present. EDEM2 SNPs were associated with PC levels, but their effect was small. PC and sEPCR levels were associated in both studies. sTM was not associated with variations of THBD or PC levels.
CONCLUSIONS: Chromosome 20 harbors genetic determinants of PC and sEPCR levels and the analysis of candidate genes suggests that the PROCR locus is responsible.
© 2011 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21392254     DOI: 10.1111/j.1538-7836.2011.04256.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  5 in total

1.  Endothelial protein C receptor expressed by ovarian cancer cells as a possible biomarker of cancer onset.

Authors:  Elodie Ducros; Shahsoltan Mirshahi; Dalel Azzazene; Sophie Camilleri-Broët; Eliane Mery; Halema Al Farsi; Hamda Althawadi; Samaher Besbess; Jean Chidiac; Eric Pujade-Lauraine; Amu Therwath; Jeannette Soria; Massoud Mirshahi
Journal:  Int J Oncol       Date:  2012-05-18       Impact factor: 5.650

2.  A genome-wide association study of the Protein C anticoagulant pathway.

Authors:  Georgios Athanasiadis; Alfonso Buil; Juan Carlos Souto; Montserrat Borrell; Sonia López; Angel Martinez-Perez; Mark Lathrop; Jordi Fontcuberta; Laura Almasy; José Manuel Soria
Journal:  PLoS One       Date:  2011-12-28       Impact factor: 3.240

3.  Endothelial protein C receptor gene variants not associated with severe malaria in ghanaian children.

Authors:  Kathrin Schuldt; Christa Ehmen; Jennifer Evans; Juergen May; Daniel Ansong; Juergen Sievertsen; Birgit Muntau; Gerd Ruge; Tsiri Agbenyega; Rolf D Horstmann
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

4.  Elucidating mechanisms of genetic cross-disease associations at the PROCR vascular disease locus.

Authors:  David Stacey; Lingyan Chen; Paulina J Stanczyk; Joanna M M Howson; Amy M Mason; Stephen Burgess; Stephen MacDonald; Jonathan Langdown; Harriett McKinney; Kate Downes; Neda Farahi; James E Peters; Saonli Basu; James S Pankow; Weihong Tang; Nathan Pankratz; Maria Sabater-Lleal; Paul S de Vries; Nicholas L Smith; Amy D Gelinas; Daniel J Schneider; Nebojsa Janjic; Nilesh J Samani; Shu Ye; Charlotte Summers; Edwin R Chilvers; John Danesh; Dirk S Paul
Journal:  Nat Commun       Date:  2022-03-09       Impact factor: 17.694

5.  Severe malaria is associated with parasite binding to endothelial protein C receptor.

Authors:  Louise Turner; Thomas Lavstsen; Sanne S Berger; Christian W Wang; Jens E V Petersen; Marion Avril; Andrew J Brazier; Jim Freeth; Jakob S Jespersen; Morten A Nielsen; Pamela Magistrado; John Lusingu; Joseph D Smith; Matthew K Higgins; Thor G Theander
Journal:  Nature       Date:  2013-06-05       Impact factor: 49.962

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.